The technical support team of Geneus Technologies and the teachers of Shanghai Institute of Health

Recently, the first product of Geneus Technologies'' G-seq500 nanopore gene sequencer was successfully shipped to Shanghai Institute of Biomedical Technology (hereinafter referred to as Shanghai Institute of Biological Research), which opened the practical application of "nanopore sequencing while synthesis" gene detection technology on the client side.

In the field, the out-of-the-box feature of the product greatly simplifies the installation process. Subsequently, the technical support staff of Geneus technology introduced the principle of "synthesis while nanopore sequencing" technology based on independent patents to the researchers of Shanghai Health Research Institute and provided on-site operational training.

Field operation training

Geneus G-seq500 gene sequencer

Dr. Yunpeng Su, CEO of Geneus Technologies, said, "We are very pleased to deliver our first gene sequencer to the Shanghai Institute for Biological Studies, which is an important milestone for our company. Geneus G-seq500 nanopore gene sequencer uses China''''s own patented technology, which has the characteristics of low cost, high precision, high efficiency, high flexibility, etc., which can provide more accurate and comprehensive data support for the research in the field of biomedicine... We believe that this device will be of great help to sequencing applications at the Shanghai Institute for Biological Studies."

Professor Zheng Huajun of Shanghai Institute of Health and Research said, "We are very much looking forward to the application of this gene sequencer. We believe that this device will provide strong support for our scientific research work and help us better carry out technical research related to genetic disease and pathogen detection."

Dr. Su Yunpeng, CEO of GeneusTechnology (left) and Professor Zheng Huajun of Shanghai Institute of Health and Research (right)

As early as May this year, Geneus Technologies and Shanghai Health Research Institute held a cooperation signing and joint laboratory licensing ceremony in Shanghai. Based on the single-molecule nanopore sequencer product, which is now the independent intellectual property of science and technology, and relying on the scientific research capability and professional technical level of Shanghai Institute of Health Research in the fields of pathogenic biology, reproductive health, precision diagnosis and treatment, the two sides will carry out research on the construction of nanopore sequencing database technology, automated data analysis methods and the development of clinical application products, and promote the rapid development of gene sequencing applications. This time, the equipment put into operation in the joint laboratory will further promote the progress of cooperation between the two sides and achieve a full range of application outputs of the platform.

Geneus Technologies has begun to accept business orders, if you are interested in our nanopore gene sequencer, welcome to call us：028-87455350。